Careful Drug History is Key: Dr Abdul Mannan on Diagnosing Drug-Induced Immune Haemolytic Anaemia
Dr Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, posted on LinkedIn:
”Sometimes diagnosing drug-induced immune haemolytic anaemia (DIIHA) feels like chasing a unicorn among zebras. What looks like a straightforward AIHA can suddenly turn on its head when a culprit drug is revealed.
A decade of pharmacovigilance data from France has now reminded us that the “usual suspects” (antibiotics, anti-inflammatories, etc.) are no longer alone – immune checkpoint inhibitors have officially joined the list.
The lesson is clear:
Never underestimate the power of a careful drug history.
A positive DAT is not the end of the story – it’s the start of the detective work.
Always challenge your diagnostic assumptions before risking re-exposure.
As our therapeutic toolbox expands, so too does the responsibility to spot these rare but serious events. Grateful for the international haematology community that keeps pushing vigilance forward and protecting patients.”
Read the full article here.
Title: A decade of pharmacovigilance in France: Immune checkpoints join the list of usual suspects for drug-induced immune haemolytic anaemia
Authors: Guillaume Brenac, Anne Dautriche, Romane Freppel, Anthony Facile, Bruno Revol, Mathilde Beurrier, Bernard Bonnotte, Sylvain Audia
Stay updated with Hemostasis Today.
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda
-
Aug 11, 2026, 05:38Rami Unterman: A Simple New Biomarker for Fibrotic ILDs
-
Aug 11, 2026, 04:10Haroun Gajraj: CLaCS vs Sclerotherapy – What Does the Evidence Show